Nucala (mepolizumab)

pCPA File Number: 22092
Negotiation Status:
Under consideration for negotiation
Indication(s):
severe chronic rhinosinusitis with nasal polyps
Sponsor/Manufacturer:
GlaxoSmithKline Inc.
CADTH Project Number:
SR0735
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable